ASP Isotopes Inc.

ASP Isotopes Inc.(ASPI)股票分析

$2.030

-0.025 (-1.22%)收盤時

Loading chart…
最高
2.180
開盤
2.000
成交量加權均價
2.06
成交量
4.07M
市值
157.36M
最低
1.970
成交金額
8.39M
企業價值/稅息折舊攤銷前利潤(TTM)
-0.96

ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. Its proprietary technologies, the Aerodynamic Separation Process and Quantum Enrichment technology, are designed to enable the production of isotopes used in several industries. Its initial focus is on the production and commercialization of enriched Carbon-14 (C-14), Silicon-28 (Si-28) and Ytterbium-176 (Yb-176). It is also a provider of liquid helium with operations at the Virginia Gas Project in South Africa. Its nuclear fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its specialist isotopes and related services segment is focused on research and development of technologies and methods used to separate isotopes for highly specialized target end markets.

AI 分析 of ASP Isotopes Inc. (ASPI)

持有

ASP Isotopes Inc is not a good buy right now due to its current price of 2.14, a very low RSI of 23.99 indicating oversold conditions, and a significant 5-day change of -19.25%. While there are positive catalysts such as a projected revenue of approximately $14 million for 2026, the risks associated with a high forward P/E and negative net income trends suggest caution.

估值指標

ASP Isotopes Inc.(ASPI)目前預期本益比為 54.35,5 年平均預期本益比為 -1.85。

預期本益比

高估
5 年均值 P/E
-1.85
目前P/E
54.35
高估
33.28
低估
-36.98

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-2.60
目前EV/EBITDA
-0.96
高估
30.88
低估
-36.08

預期股價營收比

合理
5 年均值 P/S
13.95
目前P/S
5.45
高估
24.28
低估
3.61

持有 ASPI 的大戶

E

Encompass Capital Advisors LLC

+ 持有ASPI

-4.15%

3個月報酬率

事件時間軸

2026-10-05 (ET)

09:00:00

Latest Data Shows Serve Robotics Borrow Rate Increases to 48.72%

2026-09-29 (ET)

09:00:00

Latest Data Shows Blackstone Borrow Rate Rises to 128.82%

2026-08-20 (ET)

09:30:00

ASP Isotopes Subsidiary Tetra4 Starts Liquid Helium Plant Commissioning

2026-07-21 (ET)

09:30:00

ASP Isotopes Subsidiary Signs Uranium Hexafluoride Research Agreement

2026-07-16 (ET)

17:30:00

ASP Isotopes Files to Sell 23.16M Shares of Common Stock

資訊

ASPI 常見問題 —— 由 Alphio AI 解答

ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. Its proprietary technologies, the Aerodynamic Separation Process and Quantum Enrichment technology, are designed to enable the production of isotopes used in several industries. Its initial focus is on the production and commercialization of enriched Carbon-14 (C-14), Silicon-28 (Si-28) and Ytterbium-176 (Yb-176). It is also a provider of liquid helium with operations at the Virginia Gas Project in South Africa. Its nuclear fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its specialist isotopes and related services segment is focused on research and development of technologies and methods used to separate isotopes for highly specialized target end markets. It operates in the Healthcare sector (MISCELLANEOUS CHEMICAL PRODUCTS industry).

ASP Isotopes Inc is not a good buy right now due to its current price of 2.14, a very low RSI of 23.99 indicating oversold conditions, and a significant 5-day change of -19.25%. While there are positive catalysts such as a projected revenue of approximately $14 million for 2026, the risks associated with a high forward P/E and negative net income trends suggest caution.

dawn_badger2026/9/26

$ASPI Every year, I tend to have one weak spot in my portfolio. This year, it’s this one. What a disappointment! Monthly chart.

展開
註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易